Panel Discussion: A New Paradigm in Therapeutic Development for AKI: Reenergizing Predictive Biomarkers, Clinical Studies & Endpoint Development

Time: 3:00 pm
day: Seminar Day


• What can we learn from clinical setbacks in AKI?
• Driving collaboration to forge a new clinical pathway and aligning on payer interests
• Imaging, serum markers and eGFR: what’s on the horizon and what is needed to validate a new endpoint?